Pharma Journalist -

Sanofi and Regeneron Pharmaceuticals announced that a Phase 2 proof-of-concept trial evaluating the investigational IL-33 antibody REGN3500 (SAR440340) met the primary endpoint of…
Read More...

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada)  announced that Lynparza (olaparib) has been approved in Japan as a…
Read More...

Amgen and the University of Washington's Institute for Protein Design (IPD), which is revolutionizing its field of science by creating custom-designed proteins from scratch to improve…
Read More...

Gilead Sciences, Inc. and Nurix Therapeutics, Inc., a company discovering drugs that harness the body’s natural process to control protein levels, today announced a global strategic…
Read More...

Pfizer Inc. and Array BioPharma Inc. announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array, a commercial stage biopharmaceutical…
Read More...

WuXi Biologics announced that it planned to expand the new state-of-the-art integrated biologics conjugation solution center to include commercial manufacturing in Wuxi city, China.…
Read More...

Axovant Gene Therapies Ltd.  announces that it has signed a strategic partnership with Yposkesi, a leading Contract Development and Manufacturing Organization (CDMO) for preferred…
Read More...

Gamida Cell Ltd. and Lonza announced that the companies have entered into a strategic manufacturing agreement. The agreement provides for the future commercial production after…
Read More...

SMi reports: Senior expert from Pfizer will be hosting a post-conference workshop during Lyophilization USA 2019, taking place in Boston this October. At the 5th Annual…
Read More...

Ricoh Company, Ltd., (Tokyo, Japan) announced it has entered into a strategic business partnership with Elixirgen Scientific, Inc., (Baltimore, Maryland, USA), to develop innovative…
Read More...